Here are 12 statistics on average ophthalmologist compensation based on practice situation and setting, according to the Medscape Ophthalmologist Compensation Report: 2013.
Ophthalmology
David Oliver Relin has written the book "Second Suns," which features the work of Geoffrey Tabin, MD, of the University of Utah's John A. Moran Eye Center in Salt Lake City, and Sanduk Ruit, MD.
St. Michael's Eye & Laser Institute in Largo, Fla., is constructing an additional location, which will include a surgery center and additional services, according to a Largo Patch report.
Jeffrey Martin, MD, board-certified ophthalmologist, and the surgeons of North Shore Eye Care are the first in the Suffolk County area of Long Island, N.Y., to implant the Tecnis toric intraocular lens for astigmatism correction in cataract patients.
The National Resident Matching Program, a non-profit organization designed to match prospective residents with residency program directors, has named Kenneth Simons, MD, as a board member, according to a Wauwatosa NOW report.
Advertisement
M. Roy Wilson, MD, ophthalmologist and director of strategic scientific planning and program coordination at the National Institute on Minority Health and Health Disparities in Bethesda, Md., has been chosen as the next president of Wayne State University in Detroit,…
Meera Ramanathan, MD, of the Jules Stein Eye Institute at the University of California in Los Angeles, and a team of researchers have identified three predictive factors that determine the risk of progression and visual loss in open-angle glaucoma patients,…
In the UK, Bayer Pharmaceuticals, based in Leverkusen, Germany, has earned approval from the National Institute for Health and Care Excellence for its Eylea as a wet age-related macular degeneration treatment, according to a report by thepharmaletter.
The American Academy of Ophthalmology has released a statement warning Congress of the unintended results of the proposed Pharmaceutical Compounding Quality and Accountability Act, which seeks to crack down on oversights of compounding pharmaceuticals.
BIOLASE, an Irvine, Calif.-based dental laser development and distribution company, has announced that it has earned a U.S. patent covering its laser technologies as a treatment of ophthalmic conditions.